Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Xie, Bang Wen ^a   Mol, Isabel M ^a   Keereweer, Stijn ^b   van Beek, Ermond R ^a   Que, Ivo ^a   Snoeks, Thomas J A ^a   Chan, Alan ^c   Kaijzel, Eric L ^a   Löwik, Clemens W G M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; LUCIFERASE; BENZENESULFONIC ACID DERIVATIVE; DIAGNOSTIC AGENT; INDOLE DERIVATIVE; IRDYE 800CW;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BREAST CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MODEL; FLUORESCENCE IMAGING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR GROWTH; ANIMAL; DIAGNOSTIC IMAGING; DISEASE COURSE; EXPERIMENTAL NEOPLASM; INSTRUMENTATION; LUMINESCENCE; METHODOLOGY; PATHOLOGY;

MUS; MUS MUSCULUS;

ANIMALS; BENZENESULFONATES; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FLUORESCENT DYES; INDOLES; LUMINESCENT MEASUREMENTS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE;

EID: 84856907090     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031875     Document Type: Article

References (44)

1. Kaijzel EL, Snoeks TJ, Buijs JT, van der Pluijm G, Lowik CW, (2009) Multimodal imaging and treatment of bone metastasis. Clin Exp Metastasis 26: 371-379.
2. Kim JB, Urban K, Cochran E, Lee S, Ang A, et al. (2010) Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One 5: e9364.
3. Mezzanotte L, Que I, Kaijzel E, Branchini B, Roda A, et al. (2011) Sensitive dual color in vivo bioluminescence imaging using a new red codon optimized firefly luciferase and a green click beetle luciferase. PLoS One 6: e19277.
4. Bhardwaj V, Ankola DD, Gupta SC, Schneider M, Lehr CM, et al. (2009) PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat. Pharm Res 26: 2495-2503.
5. Bharadwaj AG, Kovar JL, Loughman E, Elowsky C, Oakley GG, et al. (2009) Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Am J Pathol 174: 1027-1036.
6. Chia JS, Du JL, Hsu WB, Sun A, Chiang CP, et al. (2010) Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid. BMC Cancer 10: 175.
7. Ciampricotti M, Vrijland K, Hau CS, Pemovska T, Doornebal CW, et al. (2010) Development of metastatic HER2(+) breast cancer is independent of the adaptive immune system. J Pathol.
8. Castano AP, Liu Q, Hamblin MR, (2006) A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy. Br J Cancer 94: 391-397.
9. Keereweer S, Kerrebijn JD, van Driel PB, Xie B, Kaijzel EL, et al. (2010) Optical Image-guided Surgery-Where Do We Stand? Mol Imaging Biol.
10. Weissleder R, Ntziachristos V, (2003) Shedding light onto live molecular targets. Nat Med 9: 123-128.
11. Kovar JL, Simpson MA, Schutz-Geschwender A, Olive DM, (2007) A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. Anal Biochem 367: 1-12.
12. Rice BW, Contag CH, (2009) The importance of being red. Nat Biotechnol 27: 624-625.
13. Keppler D, Sameni M, Moin K, Mikkelsen T, Diglio CA, et al. (1996) Tumor progression and angiogenesis: cathepsin B & Co. Biochem Cell Biol 74: 799-810.
14. Garcia M, Platet N, Liaudet E, Laurent V, Derocq D, et al. (1996) Biological and clinical significance of cathepsin D in breast cancer metastasis. Stem Cells 14: 642-650.
15. Kim J, Yu W, Kovalski K, Ossowski L, (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94: 353-362.
16. Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, et al. (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A 101: 17867-17872.
17. Chen J, Tung CH, Allport JR, Chen S, Weissleder R, et al. (2005) Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation 111: 1800-1805.
18. Zhang W, Matrisian LM, Holmbeck K, Vick CC, Rosenthal EL, (2006) Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 6: 52.
19. Kovar JL, Johnson MA, Volcheck WM, Chen J, Simpson MA, (2006) Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol 169: 1415-1426.
20. Kovar JL, Volcheck WM, Chen J, Simpson MA, (2007) Purification method directly influences effectiveness of an epidermal growth factor-coupled targeting agent for noninvasive tumor detection in mice. Anal Biochem 361: 47-54.
21. Kovar JL, Volcheck W, Sevick-Muraca E, Simpson MA, Olive DM, (2009) Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem 384: 254-262.
22. Zhou H, Luby-Phelps K, Mickey BE, Habib AA, Mason RP, et al. (2009) Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice. PLoS One 4: e8051.
23. Pelicano H, Martin DS, Xu RH, Huang P, (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25: 4633-4646.
24. Flier JS, Mueckler MM, Usher P, Lodish HF, (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235: 1492-1495.
25. Kraus MH, Popescu NC, Amsbaugh SC, King CR, (1987) Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6: 605-610.
26. Lacroix H, Iglehart JD, Skinner MA, Kraus MH, (1989) Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene 4: 145-151.
27. Stebbing J, Thiyagarajan A, Surendrakumar V, Payne R, Krell J, et al. (2011) Epidermal growth factor receptor status in early stage breast cancer is associated with cellular proliferation but not cross-talk. J Clin Pathol.
28. Mayes P, Dicker D, Liu Y, El-Deiry W, (2008) Noninvasive vascular imaging in fluorescent tumors using multispectral unmixing. Biotechniques 45: 459-460, 461-454.
29. Pulaski BA, Ostrand-Rosenberg S, (1998) Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res 58: 1486-1493.
30. Aslakson CJ, Miller FR, (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52: 1399-1405.
31. Levenson RM, Lynch DT, Kobayashi H, Backer JM, Backer MV, (2008) Multiplexing with multispectral imaging: from mice to microscopy. ILAR J 49: 78-88.
32. Jenkins DE, Oei Y, Hornig YS, Yu SF, Dusich J, et al. (2003) Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20: 733-744.
33. van der Vorst JR, Hutteman M, Gaarenstroom KN, Peters AA, Mieog JS, et al. (2011) Optimization of near-infrared fluorescent sentinel lymph node mapping in cervical cancer patients. Int J Gynecol Cancer 21: 1472-1478.
34. Schaafsma BE, Mieog JS, Hutteman M, van der Vorst JR, Kuppen PJ, et al. (2011) The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 104: 323-332.
35. Levitzki A, (2003) EGF receptor as a therapeutic target. Lung Cancer 41 (Suppl 1): S9-14.
36. Patel S, Sumitra G, Koner BC, Saxena A, (2011) Role of serum matrix metalloproteinase-2 and-9 to predict breast cancer progression. Clin Biochem.
37. Bonine-Summers AR, Aakre ME, Brown KA, Arteaga CL, Pietenpol JA, et al. (2007) Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells. Cancer Biol Ther 6: 561-570.
38. Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, et al. (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63: 7870-7875.
39. Wendt MK, Smith JA, Schiemann WP, (2010) Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 29: 6485-6498.
40. Giancotti V, (2006) Breast cancer markers. Cancer Lett 243: 145-159.
41. Gocheva V, Joyce JA, (2007) Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6: 60-64.
42. Parker BS, Ciocca DR, Bidwell BN, Gago FE, Fanelli MA, et al. (2008) Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer. J Pathol 214: 337-346.
43. Kim EJ, Hong JE, Eom SJ, Lee JY, Park JH, (2010) Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. Breast Cancer Res Treat.
44. Frangioni JV, (2008) New technologies for human cancer imaging. J Clin Oncol 26: 4012-4021.